Episode 10
Jacob sits down with Insitro CEO Daphne Koller to discuss founding Coursera, where and how ML can drive the most impact in drug development, and if foundation models can transform core drug discovery work and edtech.
(00:00) - intro
(00:54) - Daphne’s journey
(09:18) - AI and biology discovery
(10:59) - insitro vs. traditional pharma
(20:04) - phenotyping patients
(26:01) - early mistakes
(29:51) - the future of data
(35:33) - partnering with larger pharma companies
(38:17) - impact of LLMs on biopharma
(44:04) - over-hyped/under-hyped
With your co-hosts:
@jasoncwarner - Former CTO GitHub, VP Eng Heroku & Canonical
@ericabrescia - Former COO Github, Founder Bitnami (acq’d by VMWare)
@patrickachase - Partner at Redpoint, Former ML Engineer LinkedIn
@jacobeffron - Partner at Redpoint, Former PM Flatiron Health
Published on 2 years, 6 months ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate